The abstract is read at the publisher; the summary is JClub's.
Loss of TREM2 in human iPSC-derived microglia-like cells increases cholesterol biosynthesis at baseline and alters lipid homeostasis, while oAβ42-driven inflammation is largely TREM2-independent.
- Why it matters: TREM2 is linked to Alzheimer’s disease risk and microglial function, but how it shapes downstream pathways—especially under oligomeric amyloid-β42 stress—remains unclear.
- What they did: The study compared transcriptomic and lipidomic profiles in TREM2 knockout and isogenic control iMGLs at baseline and after oAβ42 exposure, then tested toll-like receptor signaling inhibition.
- The result: Baseline shows TREM2-dependent gene programs resembling DAM and disease-associated signatures, and oAβ42 induces inflammatory pathways largely without TREM2 dependence; cytokine output and triglycerides/lactosylceramides rise in both lines, while TREM2 KO shows decreased BMPs and increased cholesterol esters.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.